The first genetic test to assess the risk of developing type 2 diabetes has been launched by an Icelandic company .
Decode Genetics Inc. has created a test that studies the population in order to find the genetic cause of common diseases, including diabetes. The biotech company is looking to charge a set amount per test, which in the case of diabetes will determine whether or not an individual has a twofold genetic risk of developing the disease.
The company will be able to alert would-be diabetics early o, allowing them to take greater action to reduce their risk of diabetes. The chief executive of Decode, Kari Stefansso, reportedly said: “This happens to be a risk that you can do something about.”
The first test is just the start, with Decode looking to put a number of different tests for different risks onto the market in the next few years. This type of diagnostic test is relatively new, and Decode are the first to market in this field.
The news is good for both the diabetic community and healthcare resources for the future.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…